{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04648202: Phase 1 Interventional Active, not recruiting Advanced Cancer
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Class:
CONCEPT
Status:
Investigational
Source:
NCT04074759: Phase 1 Interventional Terminated Advanced Solid Tumors
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04442126: Phase 1/Phase 2 Interventional Terminated Advanced Solid Tumor
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03696771: Phase 1 Interventional Completed NON-breast HER2+ Malignancies
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02310464: Phase 1 Interventional Completed Metastatic Gastric Cancer
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04185220: Phase 1 Interventional Completed Adult T-Cell Lymphoma/Leukemia
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03802955: Phase 1 Interventional Completed Solid Tumor
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04586153: Phase 2/Phase 3 Interventional Completed COVID-19
(2021)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03895112: Phase 1 Interventional Completed Primary Myelofibrosis
(2019)
Source URL:
Class:
CONCEPT